• Title/Summary/Keyword: Hetero Diels-Alder

Search Result 12, Processing Time 0.024 seconds

Synthesis and In vitro Evaluation of 4-Substituted-1-azaanthraquinones

  • Lee, Hee-Soon;Hong, Seoung-Soo;Choi, Jae-Young;Cho, Jung-Sook;Kim, Young-Ho
    • Archives of Pharmacal Research
    • /
    • v.21 no.1
    • /
    • pp.73-75
    • /
    • 1998
  • In summary, six 4-substituted-1-azzanthraquinones were designed and synthesized using hetero Diels-Alder reaction as a key step. Although a great number of reaction conditions for benzylic bromination were examined, this step need to be improved for the efficient synthesis of the related analogues. 4-Bromomethyl-1-azzanthraquinone 6 may have potential for the treatment of tumors resistant to the doxorubicin. The compounds 9 and 10 containing the latent alkylating functionality may need further in depth biological evaluation. Work is in progress to design, synthesize, and evaluate additional compounds in this and related systems.

  • PDF

Ab initio Studies on the Hetero Diels-Alder Cycloaddition

  • 이본수;김찬경;최정욱;이익준
    • Bulletin of the Korean Chemical Society
    • /
    • v.17 no.9
    • /
    • pp.849-853
    • /
    • 1996
  • Hetero Dieis-Alder reactions containing phosphorus atom at various positions of diene and dienophile as well as standard Dieis-Alder reaction between ethylene and cis-l,3-butadiene have been studied using ab initio method. Activation energy showed a good linear relationship with the FMO energy gap between diene and dienophile, which can be normally used to explain Dieis-Alder reactivity. Since π-bond cleavage and σ-bonds formation occur concertedly at the TS, geometrical distortion of diene and dienophile from the reactant to the transition state is the source of barrier. Based on the linear correlations between activation barrier and deformation energy, and between deformation energy and π-bond order change, it was concluded that the activation barrier arises mainly from the breakage of π-bonds in diene and dienophile. Stabilization due to favorable orbital interaction is relatively small. The geometrical distortions raise MO levels of the TS, which is the origin of the activation energy. The lower barrier for the reactions of phosphorus containing dienophile (reactions C, D, and E) can be explained by the electronegativity effect of the phosphorus atom.

Examination for Hetero Diels-Alder Reactions of 4-Acetoxyazetidin-2-one Derivatives (4-Acetoxyazetidin-2-one 유도체의 헤테로 Diels-Alder 반응 특성 조사)

  • Jeon, Pyo Myeong;Lee, Yun Yeong;Gu, Yang Mo
    • Journal of the Korean Chemical Society
    • /
    • v.38 no.9
    • /
    • pp.676-681
    • /
    • 1994
  • Diels-Alder adducts, carbacephems were obtained when 4-acetoxyazetidine-2-one or (3R,4R)-4-acetoxy-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]azetidin-2-one was reacted with 2-(tert-butyldimethylsilyloxy)-1,3-butadiene or with 3-(tert-butyldimethylsilyloxy)-1,3-pentadiene. When tert-butyldiemethylsilyl acrylate was used as the diene, products in which was acetoxy group of 4-acetoxyazetidin-2-one derivatives was substituted by an acryloyloxy group were isolated. When the same reaction was carried out with 4-phenylsulfonylazetidin-2-one as a dienophile with 2-(tert-butyldimethylsilyloxy)-1,3-butadiene, 4-phenylsulfoyl-2-butanone was obtained instead of the expected carbacephem. When dimeric form of thiochalcone was reacted with 4-acetoxyazetidin-2-one in the presence of zinc chloride, the $\beta-lactam$ ring of the azetidin-2-one was destructed and no product was isolated. Also, the reaction of 2-trimethylsilyloxy-1-aza-1,3-butadiene, which was obtained from N-methylacrylamide by treatment of trimethylsilyl trifluoromethanesulfonate in the presence of triethylamine, with 4-acetoxyazetidin-2-one did not give any products.

  • PDF

Pretreatment for Improving Selective Hydrogenation Reaction of α, β-Unsaturated Aldehydes (α, β-불포화 알데히드의 선택적 수소화 반응성 향상을 위한 전처리 방법)

  • Kook-Seung Shin;Mi-Sun Cha;Chang-Soo Lee
    • Korean Chemical Engineering Research
    • /
    • v.61 no.1
    • /
    • pp.168-174
    • /
    • 2023
  • In commercial production processes of methyl methacrylate, there is a methacryl aldehyde as an intermediate or impurities. The existence of impurities is critical factor because of significant decrease of the conversion rate and selectivity of the entire chemical reaction. This study found that an acid was the main cause of the decrease in reactivity among various impurities because an acid rapidly lowers the activity of a catalyst and promotes a side reaction, the hetero Diels-Alder reaction. Therefore, the pretreatment methods with the removal of acid were comparatively evaluated by the selective hydrogenation reaction of the carbonyl group of the reactants. Based on several experimental conditions, we believe that proposed effective pretreatment improves productivity with appropriate economical process.

Synthesis of Fluorinated New Thebaine Derivatives (불소기가 치환된 새로운 티베인 유도체 합성 -진통작용 검색 및 친화력 검토를 중심으로)

  • Kim, Keun-Jae;Kim, Su-Man
    • YAKHAK HOEJI
    • /
    • v.42 no.3
    • /
    • pp.257-264
    • /
    • 1998
  • 5-Methylthebaine was obtained by treating thebaine with n-butyllithium and methylfluorosulfonate. Hetero Diels-Alder reaction of thebaine and 5-methylthebaine with trifluoroacet aldehyde afforded 14-${\beta}$-(triflu-oro-2-hydroxyethyl)codeine (2) and 14-${\beta}$-(trifluoro-2-hydroxyethyl)-5-methylcodeinone (9). 6-${\alpha}$-OH compound (4) was obtained by employing $CeCl_2$ and $NaBH_4$. After synthesized a derivative substituted for 3-OH (5), using boron tribromied, We synthesized a new derivative that make double bond in C-7, C-8 into epoxode (6), (10). Through inspecting an influence on structure-activity and analgetic action, we are going to examine which opiold acceptor has a selectivity.

  • PDF

Synthesis and Cytotoxicity of 4-Carbamoyloxymethyl-1-azaanthraquinones (4-카바모일옥시메틸-1-아자안트라퀴논 유도체들의 합성 및 세포독성)

  • Lee, Hee-Soon;Lee, Seung-Il;Hong, Seoung-Soo;Cho, Jung-Sook;Kim, Young-Ho
    • YAKHAK HOEJI
    • /
    • v.42 no.5
    • /
    • pp.507-512
    • /
    • 1998
  • In the course of developing novel antitumor intercalating agents. We synthesized 4-carbamoyloxymethyl-l-azaanthraquinones 7-12, incorporating the latent alkylating functi onality. These compounds were designed to explore the effect of substituent on the nitrogen of carbamate. The target compounds were prepared by hetero Diels-Alder reaction as a key step followed by functionalization of benzylic methyl to the desired substituents. Growth inhibitory studies of the azaanthraquinones were conducted in vitro against human cancer cell lines (SNU-354; liver and MCF7; breast) and human epidermoid carcinoma cells that are sensitive (KB-3-1) and multidrug-resistant (KB-V-1). The compounds were less potent than doxorubicin against sensitive cell lines. However, the most active compound 12 was not cross-resistant with doxorubicin against KB-V-1.

  • PDF

Synthesis and Cytotoxicity of 3-Carbamoyloxymethyl-1-azaanthraquinones (3-카바모일옥시메틸-1-아자안트라퀴논 유도체들의 합성 및 세포독성)

  • Lee, Hee-Soon;Choi, Jae-Young;Hong, Seoung-Soo;Cho, Jung-Sook;Kim, Young-Ho
    • YAKHAK HOEJI
    • /
    • v.41 no.6
    • /
    • pp.718-723
    • /
    • 1997
  • In the course of developing novel antitumor intercalating agents, we synthesized 3- carbamoyloxymethyl-azaanthraquinones 6-12, incorporating the latent alkylating functionality. These compounds were designed to explore the effect of heteroatom incorporation into anthraquinone chromophore and the effect of the incorporation of the latent alkylating functionality. The derivatives were prepared by hetero Diels-Alder reaction as a key step followed by functionality of allylic methyl to the desired substituents. Growth inhibitory studies of the azaanthraquinones were conducted in vitro against human cancer cell lines (SNU-354: liver and MCF7: breast) and human epidermoid carcinoma cells that are sensitive (KB-3-1) and multidrug-resistant (KB-V-1). The derivatives were 10 to 100-fold less potent than doxorubicin against sensitive cell lines. However, they were marginally cross-resistant with doxorubicin against KB-V-1.

  • PDF